Literature DB >> 26381096

Intravitreal bevacizumab for choroidal metastases: the key to efficacy is simultaneous administration of systemic therapy.

N Singh1, R Bansal2, D Behera1, A Gupta2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26381096      PMCID： PMC5129790          DOI： 10.1038/eye.2015.176

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

1.  The effect of intravitreal bevacizumab treatment on choroidal metastasis of colon adenocarcinoma--case report.

Authors:  C-J Lin; K-H Li; J-F Hwang; S-N Chen
Journal:  Eye (Lond)       Date:  2009-11-06       Impact factor: 3.775

2.  Intravitreal bevacizumab in the successful management of choroidal metastases secondary to lung and breast cancer unresponsive to systemic therapy: a case series.

Authors:  V Fenicia; S Abdolrahimzadeh; G Mannino; S Verrilli; M Balestrieri; S M Recupero
Journal:  Eye (Lond)       Date:  2014-04-25       Impact factor: 3.775

Review 3.  Choroidal metastasis as a presenting manifestation of lung cancer: a report of 3 cases and systematic review of the literature.

Authors:  Navneet Singh; Pandurang Kulkarni; Ashutosh N Aggarwal; Bhagwant Rai Mittal; Nalini Gupta; Digambar Behera; Amod Gupta
Journal:  Medicine (Baltimore)       Date:  2012-07       Impact factor: 1.889

Review 4.  Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature.

Authors:  Venkata Nagarjuna Maturu; Navneet Singh; Pooja Bansal; Bhagwant Rai Mittal; Nalini Gupta; Digambar Behera; Amod Gupta
Journal:  Med Oncol       Date:  2014-03-07       Impact factor: 3.064

5.  Intravitreal bevacizumab (Avastin) for choroidal metastasis secondary to breast carcinoma: short-term follow-up.

Authors:  L Amselem; E Cervera; M Díaz-Llopis; J Montero; M Garcia-Pous; P Udaondo; S García-Delpech; D Salom
Journal:  Eye (Lond)       Date:  2006-11-24       Impact factor: 3.775

6.  Failure of intravitreal bevacizumab in the treatment of choroidal metastasis.

Authors:  A Maudgil; K S Sears; P A Rundle; I G Rennie; S M Salvi
Journal:  Eye (Lond)       Date:  2015-03-13       Impact factor: 3.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.